Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients
Condition(s):Neutropenic PatientsLast Updated:July 24, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Neutropenic PatientsLast Updated:July 24, 2019Completed
Condition(s):Parkinson DiseaseLast Updated:August 6, 2021Completed
Condition(s):Alzheimer Disease; Parkinson DiseaseLast Updated:August 6, 2021Completed
Condition(s):Kidney FailureLast Updated:January 5, 2022Completed
Condition(s):Conversion DisorderLast Updated:August 29, 2023Completed
Condition(s):Pulmonary Embolism; Pulmonary Embolism and Thrombosis; Diagnostic Errors; Embolism; Pulmonary Vascular DisorderLast Updated:June 2, 2017Unknown status
Condition(s):Sepsis Following A Procedure; Diagnoses, Syndromes, and ConditionsLast Updated:January 22, 2021Unknown status
Condition(s):Minimally Conscious State; Vegetative StateLast Updated:December 29, 2020Completed
Condition(s):Autoimmune Liver Disease, COVID-19Last Updated:October 25, 2023Active, not recruiting
Condition(s):Chronic Liver Disease; Malignant Tumor; Autoimmune Diseases; HealthyLast Updated:August 3, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.